ADA Diabetes, Obesity, and Cardiometabolic CARE (DOC CARE) Journal Symposium: The Cost of Obesity and Its Treatment-ADA Diabetes, Obesity, and Cardiometabolic CARE (DOC CARE) Journal Symposium: The Cost of Obesity and Its Treatment

ADA Diabetes, Obesity, and Cardiometabolic CARE (DOC CARE) Journal Symposium: The Cost of Obesity and Its Treatment

Video Transcription

Video Summary

The American Diabetes Association introduced its new journal, <em>Diabetes, Obesity, and Cardiometabolic Care</em>, and featured research on the health and economic impacts of obesity treatment, clinical-care challenges, and insurance coverage.

Health economist Tim Dahl described a microsimulation estimating outcomes across lifestyle programs, older and newer medications, and bariatric surgery. The model projected substantial reductions in obesity-related disease and mortality. Treating adults with obesity could generate large medical savings and productivity gains, though many benefits—such as improved quality of life and reduced mortality—do not appear in payer budgets. Estimated social returns were $3.81 per dollar invested in Medicaid and $2.35 for commercially insured populations. Speakers argued that decision-makers should weigh the costs of untreated obesity, not just treatment costs.

Physician Melanie Jay highlighted the often-unrecognized work required for effective care: securing medication access, titrating doses, managing side effects, supporting nutrition and exercise, and maintaining follow-up. Her patient case illustrated how weight loss can affect mental health and body image. She emphasized stigma, unequal access, limited clinician training, workforce shortages, and inadequate reimbursement, advocating for team-based care and better support systems.

ADA policy leader Catherine Ferguson described the fragmented U.S. insurance landscape and efforts to expand coverage through Medicare, Medicaid, state employee plans, and employers. Panelists discussed affordability, short-term return-on-investment expectations, and the need for evidence and advocacy. They also stressed prioritizing appropriate treatment, improving access for vulnerable groups, and lowering medication costs while building sustainable, comprehensive care.

Keywords

American Diabetes Association

Diabetes Obesity and Cardiometabolic Care

obesity treatment

health economics

microsimulation model

bariatric surgery

medication access

clinical care challenges

insurance coverage

Medicaid

commercial insurance

weight loss stigma

team-based care